Data from multiple sources - Curated by Toby Galbraith - Last updated 13 April 2017

Latest news articles

Added 3 days ago Drug news

FDA accepts BLA for tildrakizumab, a proposed treatment for psoriasis.- Sun Pharma.

Sun Pharmaceutical Industries Ltd announces the FDA acceptance of the Biologics License Application (BLA) for tildrakizumab. The FDA filing acceptance...

Added 3 days ago Drug news

Positive results from post approval clinical trial evaluating bronchial thermoplasty (PAS2) of Alair System in severe persistent asthma .- Boston Scientific.

Boston Scientific announced positive results from the Post Approval Clinical Trial Evaluating Bronchial Thermoplasty (BT) in Severe Persistent Asthma (PAS2)...

View all news articles

 

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Chronic Spontaneous Urticaria (CSU)

Use our patient case studies to discover how experts diagnose and treat chronic spontaneous urticaria

Visit Chronic Spontaneous Urticaria (CSU)

Bedwetting

Essential screening, diagnosis and best strategies to manage bedwetting

Visit Bedwetting

Hyperammonaemia

Hyperammonaemia can result in serious neurological damage or death. Could you recognise the signs and symptoms?

Visit Hyperammonaemia

 

Guidelines

Canadian Guidelines for the Management of Plaque Psoriasis 2009

Since the publication of the 2009 Canadian Guidelines for the Management of Plaque Psoriasis, significant advances have been made in determining the role of T cells in inflammatory and autoimmune diseases. 

Added 3 months ago

British Guideline on the Management of Asthma

Asthma is a common condition which produces a significant workload for general practice, hospital outpatient clinics and inpatient admissions.

Added 2 years ago

Adalimumab for treating moderate to severe hidradenitis suppurativa

Evidence-based recommendations on adalimumab (Humira) for treating active moderate to severe hidradenitis suppurativa in adults whose disease has not responded to conventional systemic therapy.

Added 3 months ago

View all guidelines

Journal articles

Reslizumab in patients with inadequately controlled late-onset asthma and elevated blood eosinophils.

Introduction: Asthma with adult onset and elevated blood eosinophils is a difficult-to-treat subgroup. This post hoc analysis evaluated reslizumab, an anti-interleukin-5 monoclonal antibody ...

Added 5 days ago

Reslizumab and Eosinophilic Asthma: One Step Closer to Precision Medicine?

Human eosinophils represent approximately 1% of peripheral blood leukocytes. However, these cells have the propensity to leave the blood stream and migrate into inflamed tissues.

Added 5 days ago

Reslizumab in Eosinophilic Asthma: A Review.

Reslizumab (Cinqaero®; Cinqair®) is a humanized monoclonal antibody against interleukin-5 (IL-5), a cytokine mediator of eosinophilic airway inflammation. Reslizumab is indicated as an add-on treatment ...

Added 5 days ago

View all journal articles

Clinical trials

Post-Marketing Surveillance of Adalimumab in Korean Hidradenitis Suppurativa Subjects (HS rPMS)

The objective of this study is to evaluate the safety profile of Adalimumab for Hidradenitis Suppurativa (HS) participants in normal medical practice.

Added 3 months ago

Effectiveness of Adalimumab in Moderate to Severe HidrAdenitis SuppuRativa Patients - a Multi cOuNtry studY in Real Life Setting - HARMONY Study

This study will assess the effects of adalimumab treatment in moderate to severe Hidradenitis Suppurativa (HS) patients in the real world setting.

Added 3 months ago

Safety and Efficacy of Humira (Adalimumab) for Hidradenitis Suppurativa (HS) Peri-Surgically (SHARPS Study) (SHARPS)

The objective of this study is to assess the safety and efficacy of adalimumab prior to surgery in subjects with moderate to severe Hidradenitis Suppurativa (HS) who are surgical candidates.

Added 3 months ago

View all clinical trials

Blog Posts

Hugh Harvey

Metrics Madness

Posted 1 year ago

You shouldn't judge a book by its cover. That much is true, but it's also common sense not to judge a book by measuring the whiteness of its pages, or the amount of hamsters you can place on it. So why do we measure the fabulous NHS with nonsense metrics?

Edzard Ernst

But he knows nothing about homeopathy!

Posted 1 year ago

Whenever I criticise their methods, homeopaths claim that my arguments are invalid because I know next to nothing about the subject. Is this because they feel threatened by my arguments? Or could it be that the allegation is incorrect?

You can judge for yourself - here is a (slightly shortened and revised) excerpt from my recent memoire ‘A SCIENTIST IN WONDERLAND’ which recounts my exposure to and experience in homeopathy.

Antia Veiga Feijoo

Clinical Features and Treatment Of Acute Asthma Exacerbations

Posted 1 year ago

This post discusses clinical assessment and treatment of patients with acute asthma exacerbations.

CME

Ask an expert: Psoriasis

Accrediting body
BMJ Learning - British Medical Learning
Credits available
1
Registration required
1
Subscription fee
90

Chronic Spontaneous Urticaria Case Consults: Changing Paradigms in the Age of Biologics

Chronic Spontaneous Urticaria Case Consults: Changing Paradigms in the Age of Biologics
Accrediting body
Union of European Medical Specialists (via European Accreditation Council for CME)
Credits available
1
Registration required
1
Subscription fee
FREE

Management of hidradenitis suppurativa

Accrediting body
BMJ Learning - British Medical Learning
Credits available
1
Registration required
1
Subscription fee
90
View all CME